Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Normal Pressure Catalytic Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102731324B reveals a safer, cost-effective serinol synthesis route using normal-pressure hydrazine reduction, ideal for iopamidol manufacturing.